HF

EP

IMAG

CJC

Plenary

CANADIAN JOURNAL OF CARDIOLOGY PLENARY: EMERGING THEMES IN AMYLOID HEART DISEASE

Chair(s)

• 

  Stanley Nattel

  Cardiologist and Director, Electrophysiology Research Program
  Montreal Heart Institute
  University of Montreal

Amyloidosis is a rapidly growing concern in cardiology, with the aging of the population, improvements in diagnostic tools and increasing awareness. The importance to the practicing medical professional of understanding cardiac amyloidosis has been greatly augmented by the recent approval of highly effective drugs for what was previously an untreatable condition.

This symposium provides a full update on the most recent clinically relevant discoveries in epidemiology, diagnostic challenges and technologies, and therapeutic considerations, to provide the practitioner with the understanding needed to master this important problem.

Learning Objectives

At the conclusion of this session, participants will be able to:

• understand the differences between the main forms of cardiac amyloidosis;
• learn how to avoid the pitfalls in recognizing and diagnosing amyloidosis; and
• update recent breakthroughs in amyloidosis management and learn how to apply them; and
• gain an understanding of the presentations, mechanisms and management of arrhythmias associated with cardiac amyloidosis.

Presentations:

• 2:00 PM - 2:20 PM

  CARDIAC AMYLOIDOSIS, AN EMERGING EPIDEMIC - EPIDEMIOLOGY AND CLINICAL PRESENTATION
  Diego Delgado, MD, MSc – University Health Networkd
• 2:20 PM - 2:40 PM

  CHALLENGES AND STRATEGIES IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS
  Nowell Fine, MD SM PRCPC – Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary
• 2:40 PM - 3:00 PM

  RECENT BREAKTHROUGHS IN THE TREATMENT OF CARDIAC AMYLOIDOSIS
  Sarah Cuddy – Brigham and Women's Hospital
• 3:00 PM - 3:20 PM

  AMYLOIDOSIS-ASSOCIATED CARDIAC ARRHYTHMIAS AND THROMBOEMBOLISM - CONTROVERSIES AND APPROACHES
  Margot Davis, MD SM FRCPC